Sort
48,018 grants matching “immunotherapy”
Immunologic Monitoring and Cellular Products Laboratory
$529,715Devanjan Sikder · University Of Pittsburgh At Pittsburgh · P30 · FY2025 · CA
Protocol Review and Monitoring System
$529,575Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · P30 · FY2022 · CA
Protocol Review and Monitoring System
$529,575Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · P30 · FY2023 · CA
Development of new passive immunization strategies for anthrax
$529,506Arturo Casadevall · Columbia University Health Sciences · U54 · FY2009 · AI
Human Herpesvirus 6B in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome pathogenesis: temporal analysis of viral reactivation and immunity to elucidate cause vs effect
$529,473Jackie Cliff · London Sch/Hygiene & Tropical Medicine · R01 · FY2025 · AI
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$529,462Jinming Gao · Ut Southwestern Medical Center · U01 · FY2020 · CA
Advancing T cell Therapy for Ovarian Cancer
$529,359George Coukos · Research Inst Of Fox Chase Can Ctr · P50 · FY2013 · CA
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$529,313Andre Elias Nel · University Of California Los Angeles · R01 · FY2022 · CA
Fractionated photoimmunotherapy to harness low-dose immunostimulation in ovarian cancer
$529,280Bryan Quilty Spring · Northeastern University · U01 · FY2023 · CA
Research Program in Immunology
$529,220Boston University Medical Campus · T32 · FY2005 · AI
Project 1: Costimulation and Regulation of Anti-viral Immunity
$529,207Arlene H Sharpe · Harvard Medical School · P01 · FY2015 · AI
Biomarker guided combinations for treating high-risk bladder cancer
$529,168Vinata B Lokeshwar · Augusta University · R01 · FY2024 · CA
Nanovaccine platforms to combat pancreatic cancer
$529,150Balaji Narasimhan · Iowa State University · U01 · FY2019 · CA
Project 3-Cancer cell interaction with oncogenic type 1 collagen in PDAC
$529,109Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Defining a Protective Ebola Vaccine in Non-Human Primates
$529,083Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2017 · AI
Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy
$529,077Duxin Sun · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy
$529,077Duxin Sun · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
$529,039Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$529,039Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$529,007Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Methamphetamine and HIV: Defective immunity with CD8 T cell dysfunction
$529,007Howard S. Fox · University Of Nebraska Medical Center · R01 · FY2014 · DA
Improving the translational value of head and neck cancer patient-in-mouse models
$528,946Randall J Kimple · University Of Wisconsin-Madison · R37 · FY2022 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$528,929Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Engineered antibody fragments for PET imaging of immunotherapeutic targets in gliomas
$528,929Gary Kohanbash · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Evolutionary Models of the Immune System
$528,913Melvin Cohn · Salk Institute For Biological Studies · R01 · FY2010 · RR